US$ 26.61
novo nordisk cuts prices for its glp-1 drugs. plans to slash Lilly's Zepbound price cut could
Description
The distinction matters because GLP-1 medications require functioning beta cells in the pancreas to work

Like mazdutide, it uses a C20 fatty diacid for albumin binding and weekly pharmacokinetics, but the second receptor target is GIP rather than glucagon
Metabolic and Bariatric Surgery (MBS) Source: Barrett, et al JAMA Surgery, September 17, 2025 Implications for employers: Bariatric surgery costs less than GLP-1 medications, and is likely more effective at inducing weight loss than older GLP-1 agents, which are not usually used for weight loss at this point

Its available in multiple formulations, with Ozempic and Rybelsus being some of the most well-known
These results, presented in 2024, provided the first solid evidence that GLP-1 drugs could meaningfully slow Alzheimers in humans

Read PA, Khan FZ, Dutka DP: Cardioprotection against ischaemia induced by dobutamine stress using glucagon-like peptide-1 in patients with coronary artery disease
